...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Fast cell cycle analysis for intraoperative characterization of brain tumor margins and malignancy
【24h】

Fast cell cycle analysis for intraoperative characterization of brain tumor margins and malignancy

机译:快速细胞周期分析可在术中表征脑肿瘤边缘和恶性肿瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Flow cytometry, although indispensable for the characterization of hematologic malignancies, has not been extensively evaluated in solid tumors. To date intraoperative pathology evaluation of frozen sections of tissue obtained during surgery is the gold standard for intraoperative diagnosis. We investigated the value of a modified rapid protocol for cell cycle analysis for the intraoperative characterization of intracranial lesions and their surgical margins. We investigated patients who underwent surgery for an intracranial lesion suspicious for a tumor. DNA analysis and frozen sections were performed on tumor samples that were taken during surgery. Thirty-one patients met the inclusion criteria for the study. There was a significant difference in G0/G1 phase between high-grade and low-grade tumors. Receiver operating characteristic (ROC) analysis provided 75% of G0/G1 fraction as the optimal cutoff value thresholding the discrimination between low and high-grade tumors. There was a significant difference in S-phase and mitoses fraction between high-grade and low-grade tumors. ROC analysis indicated 6% of S-phase and 9.7% of mitoses as the optimal cutoff values thresholding the discrimination between these two groups. In the glioblastoma patients, we also analyzed the perilesional tissue and found significant differences between tumor mass and margins regarding the G0/G1 phase, the S-phase and mitoses fraction. In conclusion rapid cell cycle analysis is a method capable of differentiating low from high-grade tumors and delineating tumor margins in gliomas. Thus, the role of cell cycle analysis in brain tumors warrants further investigation. (C) 2014 Elsevier Ltd. All rights reserved.
机译:尽管流式细胞术对于表征血液系统恶性肿瘤是必不可少的,但尚未在实体瘤中进行广泛评估。迄今为止,术中对组织冷冻切片的术中病理评估是术中诊断的金标准。我们调查了用于颅内病变及其手术切缘术中表征细胞周期分析的修改后的快速协议的价值。我们调查了因肿瘤可疑的颅内病变而接受手术的患者。对手术期间采集的肿瘤样本进行DNA分析和冷冻切片。共有31名患者符合该研究的纳入标准。高级别和低级别肿瘤之间的G0 / G1期存在显着差异。接受者操作特征(ROC)分析提供了G0 / G1分数的75%作为最佳阈值,从而限制了对低度和高度肿瘤的区分。在高级别和低级别肿瘤之间,S期和有丝分裂分数存在显着差异。 ROC分析表明,最佳的临界值是6%的S期和9.7%的有丝分裂,这是区分这两组的阈值。在胶质母细胞瘤患者中,我们还分析了病灶周围组织,发现肿瘤块和边缘在G0 / G1期,S期和有丝分裂分数之间存在显着差异。总之,快速细胞周期分析是一种能够区分低度和高度肿瘤并描绘神经胶质瘤中肿瘤边缘的方法。因此,细胞周期分析在脑肿瘤中的作用值得进一步研究。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号